Cargando…
Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect
Ouabagenin (OBG) is an aglycone of the cardiotonic steroid ouabain and until now was considered a biologically inactive biosynthetic precursor. Herein, we revealed that OBG functions as a novel class of ligand for the liver X receptor (LXR). Luciferase reporter assays and in silico docking studies s...
Autores principales: | Tamura, Satoru, Okada, Maiko, Kato, Shigeaki, Shinoda, Yasuharu, Shioda, Norifumi, Fukunaga, Kohji, Ui-Tei, Kumiko, Ueda, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797171/ https://www.ncbi.nlm.nih.gov/pubmed/29396543 http://dx.doi.org/10.1038/s41598-018-20663-z |
Ejemplares similares
-
A convergent total synthesis of ouabagenin
por: Mukai, Ken, et al.
Publicado: (2015) -
Development
of a Concise Synthesis of Ouabagenin and
Hydroxylated Corticosteroid Analogues
por: Renata, Hans, et al.
Publicado: (2015) -
Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benzodiazepine Recognition Site of the GABA(A) Receptor
por: Yabuki, Yasushi, et al.
Publicado: (2020) -
Physiological and Pathological Roles of CaMKII-PP1 Signaling in the Brain
por: Shioda, Norifumi, et al.
Publicado: (2017) -
Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation
por: Zhou, Enchen, et al.
Publicado: (2023)